Clinical Trials

Early clinical trial data supports amivantamab against a rare lung cancer mutation

Data-driven eligibility criteria may make clinical trials more inclusive

Predicting the success of COVID-19 clinical trials

Real-world analysis of a drug combination for malignant peritoneal mesothelioma

Brain mapping identifies therapeutic targets for neuropsychiatric symptoms

Outer product-based convolutional neural network to predict the outcome of clinical trials

Are ‘virtual patients’ the future of clinical trials?

New Alzheimer’s Drug Data Issues

Identifying Adverse Drug Reaction Mechanisms

Surrogate Endpoint Evaluation Methodology